IgG avidity test behavior in patients with cytomegalovirus disease;Comportamiento del test de avidez de IgG en pacientes con enfermedad por citomegalovirus

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 15, Issue 4, 1997, Pages 190-195

  Lafarga, Bernardo ^a   Noguera, F Javier ^a   Bolaños, Margarita ^a   Pérez, M Carmen ^a   Rodríguez, Héctor ^a  

^a Hospital Nuestra Senora del Pino   (Spain)

Author keywords

avidity index IgG; cytomegalovirus

Indexed keywords

IMMUNOGLOBULIN G;

ARTICLE; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; HUMAN CYTOMEGALOVIRUS; SEROLOGY;

ADULT; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; ANTIGENS, VIRAL; BONE MARROW TRANSPLANTATION; CYTOMEGALOVIRUS INFECTIONS; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFANT, NEWBORN; KIDNEY TRANSPLANTATION; LUPUS ERYTHEMATOSUS, SYSTEMIC; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; VIREMIA;

EID: 0030955476     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. a ed. Nueva York: Churchill Livingstone, 1995; 1.325-1.364.
2. Meyers JD, Ljungman P, Fisher LD. Cytomegalovirus excretion as a predictor of Cytomegalovirus disease after marrow transplantation: importance of Cytomegalovirus viremia. J Infect Dis 1990; 162: 373-380.
3. Stagno S, Tinker MK, Ernold C, Fuccillo DA, Cloud G, O'Beirne. Immunoglobulin M Antibodies Detected by Enzyme-Linked Immunosorbent Assay and Radioimmunoassay in the Diagnosis Cytomegalovirus infections in pregnant women and newborn infants. J Clin Microbiol 1985; 21: 930-935.
4. Cremer NE, Hoffman M, Lennette EH. Role of rheumatoid factor in complement fixation and indirect hemagglutination tests for immunoglobulin M antibody to cytomegalovirus. J Clin Microbiol 1978; 8: 160-165.
5. a ed. Washington DC: American Society for Microbiology, 1995; 884-894.
6. Van den Berg AP, Klompmaker IJ, Haagsma EB, Scholten-Sampson A, Bijleveld CMV, Schirm J et al. The TH. Antigenemia in the diagnosis and monitoring of active cytomegalovirus infection after liver transplantation. J Infect Dis 1991; 164: 265-270.
7. Pérez JL, Salvá J, Niubó J. La prueba de antigenemia para citomegalovirus. Enferm Infecc Microbiol Clin 1994; 12: 251-261.
8. Gerna G, Baldanti F, Zella D, Furione M. Detection of human Cytomegalovirus DNA: How, When and Where? Scand J Infect Dis 1995; Supl 99: 11-15.
9. Lutz E, Ward KN, Gray JJ. Maturation of antibody avidity after primary human cytomegalovirus infection is delayed in immunosuppressed solid organ transplant patients. J Med Virol 1994; 44: 317-322.
10. Blackburn NK, Besselaar TG, Schoub BD, O'Connell KF. Differentiation of Primary Cytomegalovirus Infection from Reactivation using the Urea Denaturation test for measuring Antibody Avidity. J Med Virol 1991; 33: 6-9.
11. Monto Ho. Epidemiology of Cytomegalovirus Infections. Rev Infect Dis 1990; 12, Supl 7: 701-710.
12. Hedman K, Lappalainen M, Sepälä I, Mäkelä O. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J Infect Dis 1989; 159: 736-740.
13. Inouye SA, Hasegawa S, Katow S. Changes antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturing agents is employed. J Clin Microbiol 1984; 20: 525-529.
14. Narita M, Yamada S, Matsuzono Y, Itakura O, Togashi T, Kikuta H. Immunoglobulin G Avidity Testing in Serum and Cerebrospinal Fluid for Analysis of Measles Virus Infection. Clin Diagn Lab Immunol 1996; 2: 211-215.
15. Hedman K, Rousseau SA. Measurement of Avidity of Specific IgG for Verification of Recent Primary Rubella. J Med Virol 1989; 27: 288-292.
16. De Ory F, Antonaya J, Fernández M, Echevarria JM. Application of low-avidity Immunoglobulin G studies to Diagnosis of Epstein-Barr Virus Infectious Mononucleosis. J Clin Microbiol 1993; 6: 1.669-1.671.
17. Grundy JE. Virologic and Pathogenic Aspects Of Cytomegalovirus Infection. Rev Infect Dis 1990; 12 Supl 7: 711-719.
18. Boppana SB, Britt WJ. Antiviral antibody response and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 1995; 171: 1.115-1.121.